Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  therapeutic melatonin
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-9 of 9 for your search:
Start Over
Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007077-01H, NCT00668707
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MIND, P30CA021765, NCI-2012-02053, NCT01700959
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12-08248, HM20003275, NCT02332928
Multimodal Therapy for Sleep Disturbances
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-0120, NCI-2012-01352, NCT01628029
Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MELO-D, NCT01965522
Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: MMM-1, NCT02190838
The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRI-MELAT-2013, NCT02200172
Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: MLT-MX, NCT02430298
Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: C17 MEL P1, NCT01858155
Start Over